LC
TDOC icon

Lindbrook Capital’s Teladoc Health TDOC Stock Holding History

Lindbrook Capital’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$16.5K Sell
2,076
-1,578
-43% -$16K ﹤0.01% 1437
2024
Q4 		$33.2K Buy
3,654
+1,612
+79% +$15.6K ﹤0.01% 993
2024
Q3 		$18.7K Buy
2,042
+793
+63% +$6.56K ﹤0.01% 1335
2024
Q2 		$12.2K Buy
1,249
+1,145
+1,101% +$14K ﹤0.01% 1517
2024
Q1 		$1.57K Sell
104
-412
-80% -$7.48K ﹤0.01% 2317
2023
Q4 		$11.1K Sell
516
-740
-59% -$13.7K ﹤0.01% 1494
2023
Q3 		$23.3K Buy
1,256
+5
+0.4% +$117 ﹤0.01% 999
2023
Q2 		$31.7K Sell
1,251
-261
-17% -$6.57K ﹤0.01% 879
2023
Q1 		$39.2K Sell
1,512
-2,143
-59% -$57.3K ﹤0.01% 785
2022
Q4 		$86.4K Buy
3,655
+381
+12% +$10.3K 0.01% 526
2022
Q3 		$83K Buy
3,274
+13
+0.4% +$456 0.01% 498
2022
Q2 		$108K Buy
3,261
+1,620
+99% +$68.8K 0.02% 429
2022
Q1 		$118K Buy
1,641
+146
+10% +$10.5K 0.02% 415
2021
Q4 		$137K Sell
1,495
-9
-0.6% -$1.08K 0.02% 409
2021
Q3 		$191K Sell
1,504
-10
-0.7% -$1.46K 0.05% 153
2021
Q2 		$252K Sell
1,514
-90
-6% -$14.6K 0.06% 139
2021
Q1 		$292K Sell
1,604
-13
-0.8% -$3.02K 0.07% 122
2020
Q4 		$323K Buy
1,617
+93
+6% +$18.9K 0.08% 100
2020
Q3 		$334K Buy
1,524
+16
+1% +$3.39K 0.09% 88
2020
Q2 		$288K Sell
1,508
-203
-12% -$35.6K 0.09% 97
2020
Q1 		$265K Buy
+1,711
New +$199K 0.1% 85

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lindbrook Capital's TDOC Position: Q1 2025 in Review

Lindbrook Capital reduced its Teladoc Health (TDOC) stake by 43% in Q1 2025, selling an estimated $16K and leaving 2,076 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Lindbrook Capital first reported a position in TDOC in Q1 2020 and has held it in 21 quarters since. The position peaked at $334K in Q3 2020. 384 funds tracked by Wall St. Rank hold TDOC as of Q1 2025.

  • Lindbrook Capital held 2,076 shares of Teladoc Health worth $16.5K as of Q1 2025.
  • Lindbrook Capital sold 1,578 Teladoc Health shares in Q1 2025, an estimated $16K.
  • Teladoc Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1437 holding.
  • Lindbrook Capital first reported a position in Teladoc Health in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's Teladoc Health position peaked at $334K in Q3 2020.
  • 384 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.